Kees Nooter
203 works · 10,964 citations · h-index 56
Top works
- Isolation of infectious C-type oncornavirus from human leukaemic bone marrow cells
- Cremophor EL
- Clinical pharmacokinetics and metabolism of irinotecan (CPT-11).
- Modulation of multidrug-resistant multiple myeloma by cyclosporin
- Cremophor EL-mediated alteration of paclitaxel distribution in human blood: clinical pharmacokinetic implications.
- Characterization of a type‐C virus produced by co‐cultures of human leukemic bone‐marrow and fetal canine thymus cells
- Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump
- Expression of mdr1 and mdr3 Multidrug-resistance Genes in Human Acute and Chronic Leukemias and Association With Stimulation of Drug Accumulation by Cyclosporine
- RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.
- Disposition of Cremophor EL in humans limits the potential for modulation of the multidrug resistance phenotype in vivo.
- Expression of the multidrug resistance-associated protein (MRP) gene in human cancers.
- Multidrug resistance (mdr) genes in human cancer
- Overexpression of the MDRL gene in blast cells from patients with acute myelocytic leukemia is associated with decreased anthracycline accumulation that can be restored by cyclosporin‐A
- Expression of the multidrug resistance-associated protein (MRP) in acute and chronic leukemias.
- Quantification of apoptotic cells with fluorescein isothiocyanate-labeled annexin V in chinese hamster ovary cell cultures treated with cisplatin
- Predominance of functional multidrug resistance (MDR-1) phenotype in CD34+ acute myeloid leukemia cells
- Reversal of drug‐resistance by cyclosporin‐A in a patient with acute myelocytic leukaemia
- Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micelles
- Molecular profiling of platinum resistant ovarian cancer
- Liquid chromatographic determination of irinotecan and three major metabolites in human plasma, urine and feces